Science

How a Scientific Cartel Protects Fraudsters and Rakes in Billions of Taxpayer Dollars

Corrupt scientists rarely face accountability. The real victims are everyone else.

Seconds | 5.6.2026 12:00 PM

Share on FacebookShare on XShare on RedditShare by emailPrint friendly versionCopy page URL Add Reason to Google

Media Contact & Reprint Requests

(Illustration: Lex Villena; Midjourney)

I was 22 when my grandmother forgot me.

It took her 12 years to die from Alzheimer's. It started with little things, like where her glasses were or what day it was. Soon she didn't know who I was. For a while, she addressed me as her son, but then, as the disease ate away more of her mind, she forgot him too. Then I was the young, handsome version of her husband, until he too faded away. After a while, I was just a nice young man who came to visit her.

The rest of the time, she was afraid: waking up in an unfamiliar world, surrounded by people she'd never met, confused that she wasn't back home in Minnesota, where she'd grown up. It hit my mom the hardest. She did everything she could to take care of her own mother, watching the brilliant, kind woman she knew rot into a husk of her former self.

My grandmother died on Christmas Eve. As sad as it was, it was a blessing for my mom, who was finally freed from her duty of watching the woman she loved the most waste away.

The Alzheimer's Researcher Who Became a Poster Child for Academic Fraud

Sylvain Lesné, a neuroscientist at the University of Minnesota, published a paper in Nature in 2006 claiming to identify a specific amyloid beta protein assembly as the direct cause of memory impairment in Alzheimer's. This reinvigorated the amyloid hypothesis at a moment when skepticism about it was ramping up. The National Institutes of Health (NIH) devoted $1.6 billion to projects that mention amyloids in 2022 alone, nearly half of all federal Alzheimer's funding that year. Lesné was a star.

But there were rumblings. Numerous amyloid drugs made it to trials with billions invested by pharmaceutical companies. They failed repeatedly. A question arose in the pharmaceutical community: How can this be right? How can the trials keep failing if the underlying research is correct? 

In 2022, the Vanderbilt neuroscientist Matthew Schrag uncovered evidence that images in Lesné's paper had been manipulated. Science magazine found more than 20 suspect papers by Lesné, with over 70 instances of possible image tampering. Nature retracted the paper in June 2024. Every author except Lesné signed the retraction. Lesné himself resigned from his tenured position at the University of Minnesota on March 1, 2025, three years after his fraud was exposed.

More news and details trickled out over time. Charles Piller's 2025 book Doctored talks about the Amyloid Mafia, a nickname for a network that had prioritized novelty over replication and marginalized dissenters for decades. Anyone questioning the amyloid gospel was pushed out and watched their funding vanish.

When I first picked up that Science article, I hadn't considered academic fraud as something that was real and........

© Reason.com